CKDXF (Ceryvyn Therapeutics) Dividends Received: $0.00 Mil (TTM As of Jun. 2025)


What is Ceryvyn Therapeutics Dividends Received?

Ceryvyn Therapeutics CKDXF Dividends Received is $0.00 Mil as of Jun. 2025. The stock has 3 warning signs investors should review.

Ceryvyn Therapeutics's Dividends Received for the six months ended in Jun. 2025 was $0.00 Mil.

Ceryvyn Therapeutics's Dividends Received for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00 Mil.

Ceryvyn Therapeutics Dividends Received Related Terms

Ceryvyn Therapeutics Dividends Received Historical Data

* Premium members only.

The historical data trend for Ceryvyn Therapeutics's Dividends Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ceryvyn Therapeutics Dividends Received Chart

Ceryvyn Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Dividends Received
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ceryvyn Therapeutics Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Dividends Received Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ceryvyn Therapeutics Dividends Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Dividends Received represents dividend received on the investment in the direct cash flow method.

Dividends Received for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividends Received →
What does a Dividends Received of $0.00 Mil mean?
Ceryvyn Therapeutics (CKDXF) has a Dividends Received of $0.00 Mil as of Jun. 2025. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for Ceryvyn Therapeutics and its competitors.
Is Ceryvyn Therapeutics' Dividends Received too high?
Ceryvyn Therapeutics' current Dividends Received is $0.00 Mil.
How does Ceryvyn Therapeutics' Dividends Received compare to VRTX and REGN?
Ceryvyn Therapeutics' Dividends Received of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends Received for a Biotechnology company?
A good Dividends Received depends on the Biotechnology industry context. However, Dividends Received should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends Received mean?
A high Dividends Received can signal that a stock is expensive relative to its fundamentals. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for Ceryvyn Therapeutics and its competitors. Ceryvyn Therapeutics's current Dividends Received is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ceryvyn Therapeutics stock overvalued right now?
Ceryvyn Therapeutics (CKDXF) has a current Dividends Received of $0.00 Mil. The current Dividends Received is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends Received calculated?
Dividends Received is calculated from a company's financial statements. For Ceryvyn Therapeutics (CKDXF), the current Dividends Received is $0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ceryvyn Therapeutics Business Description

Address C/ Prime Company Compliance, 505 Little Collins Street, Level 9, Melbourne, VIC, AUS, 3000
Opthea Ltd is engaged in researching and developing novel therapeutic products that target Vascular Endothelial Growth Factors (VEGF) C, D, and R3. The Group operates in one industry and two geographical areas, namely biotechnology and healthcare, with operations in Australia and the United States. The company focuses on developing biological therapeutics for eye diseases and is currently developing a novel biologic therapy, OPT-302, for the treatment of eye conditions. Its products are based on an intellectual property portfolio covering VEGF-C, VEGF-D, and VEGF Receptor-3 targets, aimed at treating diseases associated with blood and lymphatic vessel growth and vascular leakage.